Evidence map›Paper›PMID 26111025›Full record

ReviewEpigenomics2015

Breaking TADs: insights into hierarchical genome organization.

Pedro P Rocha, Ramya Raviram, Richard Bonneau, Jane A Skok

Abstract readReview
In one paragraph

Review in Epigenomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. [An identification method of chromatin topological associated domains based on spatial density clustering].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Umifenovir Epigenetically Targets theMicrobiology spectrum · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Alterations in 3D chromatin organization contribute to tumorigenesis ofComputational and structural biotechnology journal · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pedro P RochaDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Ramya RaviramDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Richard BonneauDepartment of Biology, New York University, New York, NY 10003, USA.
Jane A SkokDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.

Funding

Role Of Nuclear Organization In Protecting Genome Stability During RecombinationR01GM086852 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLUGER, YUVAL, SKOK, JANE AMANDA · 2008 to 2016
$3.8M
Enhancer Driven Gene Regulation During Lymphocyte DevelopmentR01GM112192 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SKOK, JANE AMANDA · 2014 to 2016
$1.6M
Role of ATM and RAG in maintaining genome stability during Tcra/d rearrangement.R56AI099111 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLUGER, YUVAL, SKOK, JANE AMANDA · 2012 to 2013
$815k
The Role of RNA in Regulating recombination and allelic exclusionR21AI107069 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SKOK, JANE AMANDA · 2013 to 2014
$453k
NIAID NIH HHS R21 AI107069NIAID NIH HHS R21AI107069NIAID NIH HHS R56 AI099111NIGMS NIH HHS R01 GM086852NIGMS NIH HHS R01 GM112192NIGMS NIH HHS R01GM112192PHS HHS R56 A1099111
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromatin Assembly and DisassemblyGenome, HumanAnimalsChromosomesHumanschromosome confirmation capturegene regulationHi-Cnuclear organizationTADs

Identifiers

PMID26111025
PMCPMC4624204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.